Clinical Accuracy of the welloStationX

Sponsor
Wello Inc. (Industry)
Overall Status
Completed
CT.gov ID
NCT03758157
Collaborator
(none)
110
1
1
108

Study Details

Study Description

Brief Summary

This study evaluates the clinical accuracy of the welloStationX, an automated non-touch self-service electronic thermometer using an infrared sensor of the surface of the forehead to screen for fever.

Condition or Disease Intervention/Treatment Phase
  • Diagnostic Test: welloStationX
  • Diagnostic Test: SureTemp

Detailed Description

Traditionally, body temperature is measured using a contact thermometer placed on the forehead, in the mouth, ear, armpit or rectum. Non-contact thermometers allow a person's temperature to be taken with no contact with the person, reducing the discomfort of having to sit still for several minutes. Additionally, there is no need for disinfection between patients to occur, allowing for easier and faster use when screening large numbers of people.

This study is to evaluate the clinical accuracy of the welloStationX, a non-contact thermometer by comparing its measurements with that of the gold standard Welch Allyn SureTemp oral thermometer.

Study Design

Study Type:
Observational
Actual Enrollment :
110 participants
Observational Model:
Cohort
Time Perspective:
Other
Official Title:
welloStationX Determination of Clinical Accuracy
Actual Study Start Date :
Oct 15, 2018
Actual Primary Completion Date :
Nov 15, 2018
Actual Study Completion Date :
Nov 15, 2018

Arms and Interventions

Arm Intervention/Treatment
Temperature Measurement

Each subject will have his or her temperature measured by both the welloStationX Automated Non-Contact Thermometer and the Welch Allyn SureTemp Oral Thermometer.

Diagnostic Test: welloStationX
welloStationX is an automated electronic thermometer using an infrared sensor of the surface of the forehead to measure human body skin temperature to screen for fever.

Diagnostic Test: SureTemp
SureTemp is an oral thermometer to measure human body skin temperature.

Outcome Measures

Primary Outcome Measures

  1. Clinical Agreement Through Clinical Bias Evaluation [one day]

    Agreement through clinical bias evaluation was calculated as the Mean Bias ± Standard Deviation (SD) by subtracting the first output measurement recorded with the welloStationX thermometer (DUT) from the corresponding output measurement recorded with the Welch Allyn SureTemp oral thermometer for each subject, and then calculating the Mean Bias ± SD of the biases.

Secondary Outcome Measures

  1. Clinical Repeatability [one day]

    Clinical Repeatability was calculated using the pooled standard deviations of the triplicate measurements recorded by the welloStationX.

Eligibility Criteria

Criteria

Ages Eligible for Study:
5 Years and Older
Sexes Eligible for Study:
All
Accepts Healthy Volunteers:
Yes
Inclusion Criteria:
  • Male or female.

  • 5 years and up.

  • Signed informed consent form.

Exclusion Criteria:
  • Use of medications known to affect body temperature (for example, antipyretics, barbiturates, thyroid preparations, antipsychotics, etc.) within 3 hours of the test.

  • immunization within seven days of the test

Contacts and Locations

Locations

Site City State Country Postal Code
1 Agape Clinic Dallas Texas United States 75246

Sponsors and Collaborators

  • Wello Inc.

Investigators

  • Study Chair: Alan C Heller, Wello Inc.

Study Documents (Full-Text)

More Information

Publications

None provided.
Responsible Party:
Wello Inc.
ClinicalTrials.gov Identifier:
NCT03758157
Other Study ID Numbers:
  • Wello_X
First Posted:
Nov 29, 2018
Last Update Posted:
Jul 7, 2021
Last Verified:
Jun 1, 2021
Individual Participant Data (IPD) Sharing Statement:
No
Plan to Share IPD:
No
Studies a U.S. FDA-regulated Drug Product:
No
Studies a U.S. FDA-regulated Device Product:
Yes
Product Manufactured in and Exported from the U.S.:
No

Study Results

Participant Flow

Recruitment Details
Pre-assignment Detail
Arm/Group Title welloStationX Automated Non-Contact Thermometer
Arm/Group Description welloStationX: welloStationX is an automated electronic thermometer using an infrared sensor of the surface of the forehead to measure human body skin temperature to screen for fever.
Period Title: Overall Study
STARTED 110
COMPLETED 110
NOT COMPLETED 0

Baseline Characteristics

Arm/Group Title Temperature Measurement
Arm/Group Description welloStationX: welloStationX is an automated electronic thermometer using an infrared sensor of the surface of the forehead to measure human body skin temperature to screen for fever. SureTemp: SureTemp is an oral thermometer to measure human body skin temperature.
Overall Participants 110
Age (years) [Mean (Standard Deviation) ]
Mean (Standard Deviation) [years]
44.78
(16.14)
Sex: Female, Male (Count of Participants)
Female
74
67.3%
Male
36
32.7%
Ethnicity (NIH/OMB) (Count of Participants)
Hispanic or Latino
54
49.1%
Not Hispanic or Latino
56
50.9%
Unknown or Not Reported
0
0%
Region of Enrollment (Count of Participants)
United States
110
100%
febrility (Count of Participants)
febrile subjects (temperature >=99.5 deg. C)
33
30%
afebrile subjects (temperature < 99.5 deg. C)
77
70%

Outcome Measures

1. Primary Outcome
Title Clinical Agreement Through Clinical Bias Evaluation
Description Agreement through clinical bias evaluation was calculated as the Mean Bias ± Standard Deviation (SD) by subtracting the first output measurement recorded with the welloStationX thermometer (DUT) from the corresponding output measurement recorded with the Welch Allyn SureTemp oral thermometer for each subject, and then calculating the Mean Bias ± SD of the biases.
Time Frame one day

Outcome Measure Data

Analysis Population Description
[Not Specified]
Arm/Group Title Temperature Measurement
Arm/Group Description Each subject will have his or her temperature measured by both the welloStationX Automated Non-Contact Thermometer and the Welch Allyn SureTemp Oral Thermometer.
Measure Participants 110
Mean (Standard Deviation) [degrees Farehheit]
0.04
(0.42)
2. Secondary Outcome
Title Clinical Repeatability
Description Clinical Repeatability was calculated using the pooled standard deviations of the triplicate measurements recorded by the welloStationX.
Time Frame one day

Outcome Measure Data

Analysis Population Description
[Not Specified]
Arm/Group Title Temperature Measurement
Arm/Group Description Each subject will have his or her temperature measured by both the welloStationX Automated Non-Contact Thermometer and the Welch Allyn SureTemp Oral Thermometer.
Measure Participants 110
Number [degrees Farehheit]
0.062

Adverse Events

Time Frame One day.
Adverse Event Reporting Description
Arm/Group Title Temperature Measurement
Arm/Group Description Each subject will have his or her temperature measured by both the welloStationX Automated Non-Contact Thermometer and the Welch Allyn SureTemp Oral Thermometer. welloStationX: welloStationX is an automated electronic thermometer using an infrared sensor of the surface of the forehead to measure human body skin temperature to screen for fever. SureTemp: SureTemp is an oral thermometer to measure human body skin temperature.
All Cause Mortality
Temperature Measurement
Affected / at Risk (%) # Events
Total 0/110 (0%)
Serious Adverse Events
Temperature Measurement
Affected / at Risk (%) # Events
Total 0/110 (0%)
Other (Not Including Serious) Adverse Events
Temperature Measurement
Affected / at Risk (%) # Events
Total 0/110 (0%)

Limitations/Caveats

[Not Specified]

More Information

Certain Agreements

Principal Investigators are NOT employed by the organization sponsoring the study.

There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.

Results Point of Contact

Name/Title Alan C. Heller
Organization Wello, Inc.
Phone 469-522-5200
Email allen.heller@welloinc.com
Responsible Party:
Wello Inc.
ClinicalTrials.gov Identifier:
NCT03758157
Other Study ID Numbers:
  • Wello_X
First Posted:
Nov 29, 2018
Last Update Posted:
Jul 7, 2021
Last Verified:
Jun 1, 2021